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Abstract 
Chronic illnesses have a huge impact on health outcomes and cause disease burden. 
Although better adherence to medication has been found to associate with better health 
outcome and reduce disease burden, the level of adherence can be influenced by an 
individual’s socio-environmental factors. However, as little studies have used a framework 
model to understand medication adherence, this study aims to use the Andersen Behavioural 
Model to explain medication adherence. The Andersen Behavioural Model is a theoretical 
framework which is able to demonstrates the effects of predisposing, enabling, and need 
factors in predicting medication adherence. Data used in this cross-sectional study are taken 
from the longitudinal Florey Adelaide Male Ageing Study (FAMAS) that began in 2002. A 
total of 447 male participants aged 47 to 92 were recruited in this study, who completed the 
2015-2016 FAMAS follow-up questionnaire. The associations between factors in the 
Andersen Behaviour Model and medication adherence were analysed. The proxy measure 
used for medication adherence is the number of medication taken. While several associations 
between the Andersen Behavioural Model and medication adherence were significant, some 
were not. The significant associations were then analysed using a multiple regression model, 
to demonstrate the relationship between the significant variables and medication adherence 
after adjusting for covariates. Findings of this study show that the level of adherence can be 
influenced by a number of factors of the individuals, such as age, individual beliefs, and 
number of chronic conditions. Limitations of the present study and suggestions for future 
studies were provided.  
Keywords: Chronic Condition, Andersen Behaviour Model, Medication Adherence, 
Australia 
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CHAPTER 1 - Introduction 
1.1 Overview 
The prevalence of chronic conditions is accelerating worldwide in all regions and 
socioeconomic strata, as well as being responsible for about 60% of global deaths (World 
Health Organisation, 2002). The death rate caused by chronic conditions is also relatively 
high in Australia, as the Australian Institute of Health and Welfare (AIHW, 2011) has 
reported chronic conditions account for nearly 90% of all Australian death. In addition, the 
AIHW reports nearly half of the Australia population have at least one chronic condition 
(AIHW, 2016). Furthermore, approximately one-third of the world population is diagnosed 
with multi-comorbidity (Marengoni et al., 2009), and one-fifth of the Australian population 
has multi-comorbidity (AIHW, 2016). The most common chronic conditions found in 
Australia include arthritis, asthma, back pain, cancer, cardiovascular disease, chronic 
obstructive pulmonary disease, diabetes, and mental health conditions (AIHW, 2016). 
A chronic condition is a long-term health condition which has a persistent impact 
throughout a person’s life (AIHW, 2016). The AIHW (2018) has reported that chronic 
conditions contribute up to 61% of disease burden. The disease burden can be measured by 
the extent of financial cost, disability, and morbidity suffered by the individuals due to their 
chronic conditions. Aligning with this, one of the leading cause of disability and morbidity in 
Australia is contributed by chronic conditions (AIHW, 2018). Moreover, disease burden 
negatively impacts the individuals’ quality of life as they have trouble functioning properly 
on a daily basis. As a result, the disease burden leads to lower physical and social functioning 
(Deshpande et al., 2011). For instance, individuals with chronic conditions are more likely to 
experience breathing difficulties, seizures, and impairments. Furthermore, different chronic 
conditions result in different impairments and restrictions. An example provided by the 
AIHW (2015) was people with back pain, arthritis, and osteoporosis have a higher prevalence 
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of experiencing chronic pain and discomfort than people with asthma and diabetes. Thus, 
people with chronic conditions may need to make adjustments to their aspiration, lifestyle, 
and employment, in order to accommodate their needs for chronic conditions. Other than 
physical impact, chronic conditions also take a psychological and emotional toll on the 
individuals, making them more prone to low esteem, shame and guilt, hence resulting in 
anxiety and depression (Hemati & Kiani, 2016; Turner-Cobb et al., 2015; Turner & Kelly, 
2000). Research has found that low esteem causes greater stress severity, which can then 
result in greater severity of symptoms of chronic conditions in the individuals’ daily life (Juth 
et al., 2008). Chronic conditions severely impact the individuals’ life physically, 
psychologically, and emotionally. Thus, the individuals may need to learn some coping 
strategies to deal with their stress in relation to chronic conditions, in order to control for their 
symptom severity of chronic conditions.  
The chronic condition is associated with a high rate of hospitalisation and the leading 
cause of death in Australia (AIHW,2018). AIHW (2019a, 2019b) has reported that males 
record a higher hospitalisation and death rate due to chronic conditions as compared to 
females in Australia, as males accounting for 39% of the hospitalisation rate and female 
accounting for 35%. Although females (49%) do record a slightly higher rate of diagnosis of 
one or more common chronic conditions than males (46%), yet males account for a higher 
death rate from chronic conditions. In addition, the AIHW (2019a) reports that males are 
more likely to die of malignant cancer, coronary heart disease (e.g. heart attack/angina), and 
diabetes than females. As a result, Australian men have a shorter life expectancy of 80.5 
years when compared to Australia women, who have a life expectancy of 84.6 years (AIHW, 
2019a; AIHW, 2019b).  
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1.2 Andersen Behavioural Model 
The Andersen Behaviour Model (ABM) is a widely used theoretical framework to 
understand individuals’ health service utilisation (Andersen, 1968; Andersen, 1995).  This 
model has been successfully applied to different populations, such as Caucasian, Chinese, 
and Latino, to account for the factors that affect the utilisation of health services (Bradley et 
al., 2002; Insaf et al., 2010; Zhang et al., 2019). For instance, a study used the ABM model to 
examine factors that affected health service utilisation in Australian with arthritis and found 
enabling factors (e.g. income and healthcare insurance) were a strong predictor compared to 
need factors (e.g. comorbid conditions and physical activity) (Lo et al., 2016).  
Other than healthcare utilisation, the ABM is also capable of predicting medication 
adherence (Andersen, 1995; De Smet et al., 2006; Murray et al., 2004). De Smet et al. (2006) 
has successfully used the ABM to investigate medication adherence in asthma patients and 
concluded that it was associated with certain factors in the model such as health beliefs, 
numbers of medication per day, and perceived severity of the disease. In addition, Murray et 
al. (2004) used the ABM to examine medication adherence in patients with multiple chronic 
conditions and concluded that aging and increase in number of medications prescribed were 
associated with poorer adherence of medication.  
The ABM provides a conceptual framework for demonstrating the effects of different 
factors in predicting health service utilisation, which includes predisposing factors, enabling 
factors, and need factors. The predisposing factors include an individual’s demographic (e.g. 
age, gender) and social characteristics (e.g. education, marital status). Enabling factors 
include the barriers and facilitators of the use of health care services, such as income, health 
insurance, and service availability. Need factors represent both a perceived and evaluated 
need for health care. The perceived need refers to the individual’s belief with regard to 
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illness, while the evaluated need refers to the assessment of the health status of the individual 
by medical personnel (Andersen, 1968; Andersen, 1995).  
1.2.1 Predisposing factors 
Predisposing factors refer to the demographic variables, which includes age, marital 
status, and education level. A study has found that men who are widowed, living alone, and 
have a lower education level are more likely to have a poor adherence in taking medication 
(Uchmanowicz et al., 2018). In terms of age, research has suggested that older people are 
more likely to be diagnosed with multiple chronic conditions and thus require taking more 
prescription medications per day (Kocurek, 2009). However, even though age is a crucial 
factor in determining the rate of adherence, most studies used younger adults as the target 
population as older adults are more prone to multiple comorbidities (Yap et al., 2016).  
In terms of education level, Taibanguay et al. (2019) has conducted a study 
investigating the effect of education on medication adherence with rheumatoid arthritis 
patients and found that education has a significant effect on adherence, as the patients’ 
adherence rate significant improved after receiving education related to their disease. 
Evidence has also suggested that people with higher education levels have a better adherence 
rate due in part to enhanced health literacy (Pandey et al., 2017). This has been further 
supported by a study investigating the impact of education levels and medication adherence 
in post-Myocardial Infarction patients and found that people with lower education level had a 
significantly lower adherence rate compared to people with greater than 12 years of education 
(Pandey et al., 2017). 
 Prior research investigating adherence rate of married and unmarried patients with 
health failure concluded that unmarried patients have a lower adherence rate of medication 
(DiMatteo, 2004). Furthermore, it was found that adherence tends to be higher in individuals 
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who are married (Gagnadoux et al., 2011). One of the grounds for married patients having a 
higher adherence rate could be the social support they have received (Sherbourne & Hays, 
1990). Based on the past findings that found older people are required to take more 
medication, higher education levels have better health literacy, and people who are married 
receive more social supports, the present study hypothesised that older adults with high 
education levels who are married have higher medication adherence. 
1.2.2 Enabling factors 
Masculinity can be considered as one of the enabling factors, as it can act as a 
resource or tool that encourage an individual’s health care utilisation. Barriers faced by 
patients with chronic conditions can affect their adherence rate of medication. Past research 
has found masculinity to be strongly associated with ignorance in help-seeking behaviours 
(O'Brien et al., 2005). According to traditional masculinity, men are supposed to be strong 
and independent. Admitting having chronic conditions could be viewed as weak, which 
contradicts with masculinity identity, and thus resulting in poor help-seeking behaviour 
(Courtenay, 2000). In addition, men who conform more to masculinity norms are 
significantly less likely to engage in positive health behaviours (Mahalik et al., 2007).  
1.2.3 Need factors  
Research has indicated that the severity of chronic conditions has an impact on 
medication adherence, with people who have a more severe condition having poorer 
adherence (DiMatteo et al., 2007; Meichenbaum & Turk, 1987). The severity of chronic 
conditions comprises self-perceived severity and the actual severity of the disease. Self-
perceived severity is a measure where individuals evaluate their overall health status, 
including physical, social, and emotional status. In 2017-18, 57% of Australian males rated 
their health status as excellent or very good (AIHW, 2019a). A study has found that people 
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who perceive themselves as having a better health status tend to have better adherence to 
medication, as they would want to maintain their health (DiMatteo et al., 2002).  
Evidence has found that the actual severity of chronic conditions has an impact on the 
rate of adherence, with people who have more severe illness having a poorer adherence to 
medication (Lemay et al., 2018). This is because people with lower severity have the needs to 
keep their conditions in control (DiMatteo, 2007). Moreover, previous research has found 
that higher adherence to medication is associated with lower comorbidity (Rolnick et al., 
2013). As a result, the severity of illness has a significant impact on predicting medication 
adherence.  
1.3 Hegemonic Masculinity 
The concept of hegemonic masculinity serves as a culturally idealised form of men’s 
identity, where they should be strong, independent, and tough (Connell, 1987). Over the 
years, this concept has been commonly used, debated, and refined (Connell & 
Messerschmidt, 2005b). The American Psychological Association (APA) (2018) has stated 
that the traditional ideology of masculinity restricts the behaviour of men, as well as 
negatively affects their mental and physical health. As a result, it has been suggested that 
men's underuse of medical and healthcare services might possibly be partly explained by 
hegemonic masculinity (Davidson & Meadows, 2010), whereby men are supposed to act, 
think, and feel in a certain way based on society's expectations (Levant & Richmond, 2007). 
It has been suggested that such an ideology is derived from white, upper-middle-class, 
heterosexual, Christian values, which favour independence, strength, being the primary 
provider, initiative-taking, and having a deep voice (Connell & Messerschmidt, 2005a). Since 
it is not common for all men to exhibit all these qualities, it has been suggested that most men 
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regard hegemonic masculinity as a desired goal and not as a reality, since hegemonic 
masculinity is presented as a most honourable form of “manhood” (Connell, 1987). 
Further, previous studies have shown how masculinity can be impacted by illness. For 
instance, studies have found that having Rheumatoid Arthritis can negatively affect men’s 
sense of power and control, leading to feelings of helplessness and depression, and forcing 
them to re-interpret masculine activities within their ability (Flurey et al., 2018; Lack et al., 
2011). Moreover, the notion of being a ‘breadwinner’ is considered as a trait for hegemonic 
masculinity. However, when men are diagnosed with multiple comorbidities, they are unable 
to work full-time, causing them to lose a sense of identity of ‘being a man’ as they are not in 
the position to be the breadwinner of the household (Varekamp & van Dijk, 2010). 
Furthermore, hegemonic masculinity traits encourage men to put their health at risk in order 
to secure their masculinity identity. Aligning with this, men have found to have worse 
adherence to medication than women (Degli Esposti et al., 2002). As a result, masculinity has 
a negative impact on chronic conditions, as people with multiple chronic conditions tend to 
have a lower sense of masculinity, due to their inability to conduct certain activities that are 
considered as masculine.   
In addition, the concept of hegemonic masculinity is evolving based on the influence 
of our society and culture environment. For instance, traditional masculinity suggests that 
men should be tough and have no feeling, whereas the modern masculinity encourages men 
to understand themselves on a deep and personal level (Oliffe et al., 2019). However, 
previous quantitative research has failed to account for the contextualisation of masculinity, 
as most studies overlooking men do attend to their health (Calasanti et al., 2013). Therefore, 
as hegemonic masculinity is evolving, new masculinity measures have to take other factors 
into account, such as emotional factors.  
FACTORS AFFECTING  MEDICATION ADHERENCE  17 
 
Furthermore, there is a lack of uniformity in terms of measurement of masculinity, 
resulting in the inability to compare results from various studies. Previous research has 
defined masculinity differently by using various scales to assess masculinity, ranging from 
masculinity norms to role conflicts, masculine conceptions and ideologies. Thus, the present 
study aims to use the Masculinity in Chronic Disease Inventory (MCD-I), which measure the 
internalised masculine beliefs. Additionally, most masculinity measures were designed based 
on the normative form of hegemonic masculinity, which is Caucasian, heterosexual, and 
middle-class men (Smiler, 2004). However, these measures were then misused on the older 
population, ethnically and sexually diverse men (D Griffiths et al., 2012). Consequently, 
results may be biased, causing the findings of the study to be less valid. Therefore, the 
present study used the MCD-I measure that was developed based on Australian men, making 
the quality of findings more applicable to Australian men (Chambers et al., 2016).  
1.3.1 Chronic Condition  
Revealing chronic conditions to others can threaten men’s masculinity identity, as the 
symptoms of chronic conditions contradict with the notion of hegemonic masculinity. For 
example, having chronic conditions will result in a person experience pain, fatigue, and 
losing strength, whereas masculinity defines a man as being strong and independent (Gibbs et 
al., 2005). In addition, health care practitioners often construct men as stubborn and unwilling 
to seek help, which further reinforces men’s reluctance to seek help (Seymour-Smith et al., 
2002). Subsequently, men are less likely to admit having chronic conditions, as a way to 
protect their masculinity identity, and thus resulting in not seeking help (Courtenay, 2000). 
1.4 Medication Adherence 
Medication adherence is defined by the World Health Organization (WHO) as the 
extent to which the patient accepts the prescribed medication from their doctor in order to 
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improve the overall health of the patient by taking into account of lifestyle, values, and care 
preference (WHO, 2003). Medication adherence is a complex behaviour that has been 
associated with many aspects, such as socioeconomic status, healthcare system, and patient-
related factors (Kardas et al., 2013). WHO has reported approximately 50% of patients do not 
take their medication for chronic conditions as prescribed (WHO, 2003). Having poor 
adherence to medication leads to worsening the disease, increasing of risk for morbidity and 
lower quality of life (Bourbeau & Bartlett, 2008; Williams et al., 2008). As a result, poor 
adherence can contribute to having a shorter life expectancy (Feehan et al., 2017).  
1.4.1 Factors Contributing to Poor Adherence  
Many factors contribute to poor medication adherence, including cost, willingness, 
forgetting, medication side effects, treatment duration, and patients’ beliefs (Egan et al., 
2003; Vermeire et al., 2001). Insurance can also affect adherence rate, as medication that are 
not covered by insurance has been associated with poorer adherence (Kennedy et al., 2008). 
Another study has found that poor taste of medication also leads to poor adherence (Jin et al., 
2008). Hence, adherence rate can be affected by many factors, ranging from patient’s beliefs 
to patient’s ability to afford the medication.  
1.4.2 Level of Medication Adherence 
Less than optimal levels of medication adherence can have a negative outcome on the 
patient’s condition. For instance, previous research has investigated the association between 
the level of medication adherence and major adverse cardiovascular event (MACE) among 
patients with myocardial infarction or atherosclerotic disease. In comparison to patients with 
full medication adherence, patients with nonadherence have a significantly higher rate of 
getting MACE (18% vs 26% risk) (Bansilal et al., 2016). In addition, comorbid conditions 
reduce when patients follow their cancer treatment (Søgaard et al., 2013). Moreover, 
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evidence suggests that poor adherence results in a more intense relapse rate, leading to a 
poorer quality of life (Zhang et al., 2019). Therefore, a higher level of medication adherence 
is important in maintaining and improving the patient’s condition. 
1.4.3 Measurement of Medication Adherence 
According to Brown & Bussell (2011), measurement of medication adherence can be 
challenging as medication adherence is an individual patient behaviour. Different methods 
have been used to measure adherence such as (1) subjective measurement: interviewing the 
patient, family members, and physicians about the patient’s medication use; (2) objective 
measurement: pill counts, rates of prescription refill records, and electronic monitors; (3) 
biochemical measurements: adding a nontoxic marker into medication and detecting its 
presence in patient’s blood or urine. However, each method has its own strengths and 
weaknesses, and there is not a method that is considered as the gold standard (Jimmy & Jose, 
2011). Nonetheless, research has shown that the easiest way to measure adherence is through 
the patient’s self-report (Walsh et al., 2002). 
1.5 Research Gap 
Majority of the research in relation to the relationship between masculinity and 
medication adherence in men with chronic conditions was done in the United States (Galdas 
et al., 2005; Galvan et al., 2017). As hegemonic masculinity varies between social groupings 
and culture, what is considered as masculinity in the United States could be different from 
Australia (Connell & Messerschmidt, 2005a). Subsequently, findings in the United States 
could be different from findings in Australia, resulting in findings found based on the United 
States population to be potentially inapplicable to Australia population. Therefore, the present 
study aims to conduct research focusing on Australian men regarding the relationship 
between masculinity and medication adherence.  
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In addition, previous research fails to account for the conceptuality of masculinity, as 
the traits used in previous research are mostly based on the traditional ideal traits, instead of 
taking social reality into account. The measures used for previous studies were also 
developed based on Western hegemonic ideals, which can be less applicable to sexually and 
ethnically diverse men, especially the Australian population (D Griffiths et al., 2012). 
Therefore, the present study aims to use the Masculinity in Chronic Disease Inventory 
(MCD-I), which is a new masculinity measure developed based on the Australian population 
(Chambers et al., 2016). The MCD-I is sensitive to age and sexual health, while addressing 
the conceptuality of masculinity by using multiple factors to measure internalised masculine 
beliefs (Occhipinti et al., 2019).  
To date, no studies have used a conceptualised framework to assess factors that 
influence medication adherence. As a result, factors that were found to be significant 
predictors of medication adherence could lose its significance after taking in account of other 
covariates. Thus, the present study aims to investigate factors that influence medication 
adherence using the ABM. 
1.6 Aims and hypothesis 
 Up to this point, no study has used the Andersen Behavioural Model to explain 
medication adherence in Australian men. Thus, the current study seeks to examine the extent 
to which the Andersen Behavioural Model accounts for medication adherence in Australian 
males with chronic conditions. As mentioned above, the MCD-I is used in this study, as it is 
suitable to use on older Australian men with chronic conditions.  
The current study first identifies the predictor variables for medication adherence 
individually at a bivariate level, then examine the significant variables using the Andersen 
Behavioural Model. As a result, the aim of the current study is to investigate the extent of 
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Andersen Behavioural Model in explaining medication adherence in Australian men with 
chronic conditions. To address this aim, four objectives is implied in the present study (Table 
1).  
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Table 1  
Objectives for the Present Study 
Objective 1 To examine the influence of Predisposing Factors (age, education, and 
marital status) on men’s medication adherence 
 It is hypothesised that younger men will report lower medication adherence than 
older men.  
 It is hypothesised than people with lower education level will report lower 
medication adherence than people with higher education level. 
 It is hypothesised that married people have a higher medication adherence rate 
compared to other groups. 
Objective 2 To examine the influence of Enabling Factor (masculinity) on men’s 
medication adherence  
 It is hypothesised that people with higher masculinity level will have a lower 
medication adherence than people with lower masculinity level. 
Objective 3 To examine the influence of Need Factors on men’s medication adherence 
 It is hypothesised that people with weaker perceived need will have a lower 
medication adherence than people with stronger perceived need. 
 It is hypothesised that people with higher actual need have a lower medication 
adherence than people with lower actual need. 
Objective 4 To examine the relationship between Predisposing Factors, Enabling 
Factors, and Need Factors with medication adherence, after adjusting for 
significant covariance 
 It is hypothesised that all of the significant variables at the bivariate level will 
remain significant after putting in a model.  
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CHAPTER 2 – Methods 
2.1 Study Design 
Data used in the present study were drawn from the Florey Adelaide Male Ageing 
Study (FAMAS) that began in 2002. The FAMAS is a longitudinal study investigating 
various health-related behaviours and chronic disease status of mid to older aged men. 
Participants in the FAMAS were required to complete a follow-up questionnaire annually and 
a clinic evaluation every five years. They were required to document any changes to their 
contact details, physician details, health, and physical status. Details of the study can be 
found in Martin’s study (Martin et al., 2007).  
The present study used data previously collected in the 2015-2016 FAMAS follow-up 
questionnaire. As the present study used the Andersen Behavioural Model (ABM) to explain 
men’s medication adherence, only a subset of data is used.  
2.2 Theoretical Framework 
This study adopted the Andersen Behavioural Model (ABM) to identify the 
potentially influential factors of medication adherence. This study included age, education, 
and marital status under predisposing variables.  As the enabling factor refers to the barriers 
and facilitators of improving adherence to medication, this study included masculinity under 
the enabling factor. Need factors can be categorised into perceived need and actual need. 
Perceived need was operationalised using self-assessed health status, while the actual need 
was operationalised using the number of chronic conditions of the study participants. As 
mentioned above, there appears to be many ways of measuring adherence to medication. This 
study used the number of medications taken by the participants as the proxy measure for 
medication adherence (Figure 1).  
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Figure 1. Adopting Andersen Behavioural Model to explain potential factors that influence 
medication adherence.   
2.3 Participant Criteria 
Participants in the FAMAS were recruited through ringing the number listed in the 
Electronic White Pages (EWP) who lived in the North-West region of Adelaide. A residential 
household who is male, aged 35 to 80 years at the time of recruitment, willing to comply with 
the protocol and given consent, the last to have his birthday in the household were invited to 
participate in the study. Respondents who were considered incapable of participating in the 
study due to immobility, language barriers, living outside the catchment area, and unable to 
provide written informed consent were excluded (Martin et al., 2007).  
2.4 Participant Recruitment 
2.4.1 Sampling 
At the initial time of recruitment, there were a total of 1195 participants who 
participated in the baseline clinic visit (response rate = 45.1%) (Martin et al., 2007). Over 
time, the number of participants decreased due to loss of follow up and death. Thus, only 633 
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respondents completed the 2015-2016 follow-up questionnaire (response rate = 68.7%) 
(Occhipinti et al., 2019). 
2.4.2 Demographic Profile 
 The sample used in the FAMAS demographically reflects the State population, as the 
Northern and Western regions of Adelaide consists of over a third of the State’s population 
and comprises approximately half of Adelaide’s population. However, there are two notable 
exceptions: the younger age groups and never-married men were under-represented, while the 
older age groups were over-represented (Martin et al., 2007).   
2.5 Participants 
Of the 633 respondents who completed the 2015-2016 follow-up questionnaire, 447 
(70.6%) men were eligible for the current study as they self-reported with one or more 
chronic conditions. The participants were aged between 47 and 89 (M = 65.73, SD = 9.33). 
Data with partial responses were excluded.  
2.6 Measures 
2.6.1 Demographic information  
Basic demographic information, such as their work status, marital status, the highest 
level of education completed, and annual household income were asked (Appendix A: 
Question J1 and Section S). The age was obtained at the time of the initial recruitment in 
2002 and have been adjusted to the age at the time of survey data collection in 2015-2016. 
2.6.2 Masculinity 
 The Masculinity in Chronic Disease Inventory (MCD-I; Chambers et al, 2016) is a 
22-item self-report measure used to assess masculinity, with six subscales representing 
different aspects of masculinity: Strength (five items), Sexual Importance/Priority (four 
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items), Family Responsibilities (four items), Emotional Self-Reliance (two items), Optimistic 
Capacity (four items), and Action Approach (three items). Each item (e.g. “Being physically 
strong is important to me”) is scored on a 5-point Likert scale (1 = ‘Not at all true” to 5 = 
“Very true”) (Appendix A: Section P). The scores in each masculinity subscales were 
combined, and the overall scores from all six subscales were then totalled. The total 
masculinity score ranges from 22 to 110, with a higher score indicating a stronger 
endorsement of these masculine ideals. The MCD-I demonstrates a good internal reliability 
as the total score has a Cronbach’s α of .88, with all subscales having a high Cronbach’s α 
between .68 to .93 (Occhipinti et al., 2019).  
2.6.3 Perceived Need 
 Participants were asked to self-assess their health status. Six questions regarding how 
individuals view their health were asked. Questions such as ‘In general, would you say your 
health is excellent/ very good/ good/ fair/ poor?’ and ‘Compared to one year ago, how would 
you rate your health in general now?’ were included. All questions were rated on a 5-point 
Likert scale, with four questions using the same scale (1= “Definitely true” to 5 = “Definitely 
false”) (Appendix A: Question A1, A2, A33, A34, A35, and A36). As two reversed worded 
questions were used (A33 and A35), scores on these questions have been reversed. The total 
score of the six questions was then totalled.  
2.6.4 Actual Need 
 Participants were asked to self-report their history of diagnosed chronic conditions. A 
list of 18 chronic conditions options was then provided below (Appendix A: B1). Options of 
chronic conditions included in the questionnaire include high cholesterol, high blood 
pressure, and osteoarthritis. The participants had to self-select all of the chronic conditions 
that they had. 
FACTORS AFFECTING  MEDICATION ADHERENCE  27 
 
2.6.5 Medication Adherence 
 Medication adherence was measured by the number of medications that the 
participants were taking. Study participants were asked to self-report all the medications that 
they were taking for the past four weeks, irrespective of whether the medication was 
prescribed by the doctor or taken over-the-counter. They were first asked whether they were 
taking any medication for most of the past four weeks. Subsequently, participants were asked 
to self-report the medications they took for most of the last four weeks from a list of 32 
medications (‘Did you take any of the following? (tick ALL that apply)’). Options given in the 
list include Glucosamine, Paracetamol, and Lipitor (Appendix A: Q2). Medication conditions 
that the corresponding medication selected was treated were also asked. The number of 
medications taken was then totalled. 
2.7 Procedures 
An introductory letter, information brochure, and follow-up questionnaire were sent to 
participants’ households, inviting them to participate in the current study. Participants were 
informed that the questionnaire might possibly be similar to the previous questionnaires, as 
the purpose of the follow-up questionnaire is to update any changes over time. A reply-paid 
envelope was included for the participants to mail back the responses once it has been 
completed. Alternately, the participants could choose to complete the questionnaire through 
an online platform by using the link and log-on details provided on the front page of the 
follow-up questionnaire.  
The questionnaire took approximately 30 to 40 minutes to complete, and participants 
were given two weeks to complete and return the questionnaire. No reimbursement was 
provided to the participants. A contact number was provided on the questionnaire if the 
participants had any doubts while completing the questionnaire. Confidentiality of the 
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participants’ responses was reassured as sensitive personal information was included in the 
questionnaire.  
2.8 Statistical Analysis 
All responses were analysed using the IBM Statistical Package for the Social Sciences 
(SPSS) software, version 26.0 (IBM, 2019). Missing values and invalid data of relevant 
variables were first screened and excluded. Descriptive statistics of the participants’ 
demographic characteristics, masculinity, perceived need, actual need, and medication 
adherence were obtained. The Central Limit Theorem (CLT) is applied in this study to fulfil 
the assumption of normality as the sample size is larger than 30 (Laplace, 1810).  
The Pearson’s Product-Moment Correlation Coefficient was used to investigate the 
relationship between continuous predictor variables and medication adherence at a bivariate 
level. For categorical predictor variables, an One-way ANOVA was used to assess the 
relationship between predictor variables and medication adherence at a bivariate level. To 
determine the effects of measured variables on medication adherence, a multiple regression 
model was further used, after adjusting for significant covariates.  
2.9 Ethics  
Ethics approval was obtained from the Royal Adelaide Hospital Research Ethics 
committee in Phase 1 of the FAMAS study. Informed consent for future contact regarding 
additional studies was acquired from the study participants in Phase 1. Consent was 
considered to be given when the participants returned the questionnaire or submitted the 
online survey. Exemption from ethical approval was granted by the University of Adelaide 
Human Research Ethics Committee as this study uses previously acquired de-identified data 
from the FAMAS.  
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CHAPTER 3 – Results 
3.1 Preliminary analysis  
3.1.1 Data preparation and cleaning 
 Of the 478 respondents, 447 respondents (94%) reported having one or more chronic 
condition, which makes them eligible for the current study.  
3.2 Descriptive Statistics 
3.2.1 Demographic Profile 
 Table 2 shows the demographic characteristics of the study participants. The majority 
of the participants in the current study were men aged 60 to 69 (42%), retired (46%), married 
(77%), had the highest education level as TAFE, Apprenticeship, Trade Certificate, or 
Diploma (44%), and had a middle annual household income of $40,000 to $100,000 (43%). 
However, men aged 40-49 (3%), had the highest education level of primary school (5%), 
part-time or casual employment (9.2%), widowed (2.9%) and never married (2.9%) were 
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Table 2 
Demographic Profile of Study Participants (N=447) 
Characteristic N % 
Age (Years)   
40 – 49 15 3.4 
50 - 59 99 22.1 
60 – 69 187 41.8 
70 – 79 102 22.8 
80 - 89 44 9.8 
Educationa   
Primary School 24 5.4 
High School 143 32 
TAFE/Apprenticeship/Trade Certificate/Diploma 197 44.1 
Bachelor Degree or Higher 69 15.4 
Others 14 3.1 
Work Statusb   
Self-Employed 55 12.3 
Full-Time Employed 119 26.6 
Part-Time/Casual Employment 41 9.2 
Retired 206 46.1 
Others 26 5.7 
Marital Status   
Married 345 77.2 
Living with a Partner (defacto) 33 7.4 
Widowed 13 2.9 
Divorced 27 6.0 
Separated 16 3.6 
Never Married 13 2.9 
Annual Household Incomec   
Low 155 34.7 
Middle 193 43.2 
High 78 17.4 
Do Not Know  21 4.7 
a Highest Level of Education: primary and high school indicates either partial or full 
completion. b Work status: unemployed, home duties, student, unable to work, carer and 
others were combined into category Others. c Annual household income: low income is lower 
than $40,000 per annum, middle income is between $40,000 to $100,000 per annum, and 
high income is greater than $100 000 per annum.  
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3.2.2 Enabling Factors 
 The average total MCD-I score was 82.74 (SD = 13.13), indicating the masculinity 
level of the study participants were relatively high (Appendix B: Table B1). 
3.2.3 Need Factors 
Table 3 presents the descriptive statistics for perceived need and actual need. The 
perceived need has good reliability as the Cronbach’s alpha coefficient is .82. On average, the 
number of chronic conditions reported by the participants was 2.27 (SD = 1.46). The majority 
of the study participants were diagnosed with high blood pressure (51%), followed by high 
cholesterol (43%), then osteoarthritis (28%) (Appendix B: Table B2). 
3.2.4 Medication 
 On average, the number of medications taken by the study participants was 2.19 (SD 
= 1.81). The most common medications taken by the participants were fish oil (25%), 
paracetamol (24%), followed by aspirin (23%) (Appendix B: Table B3).  
 
Table 3  
Descriptive Statistics of Need Factors (N=447) 
Variable M Median SD Range Minimum Maximum 
Actual Needa 2.27 2.00 1.46 10 1 10 
Perceived Need 14.97 14.00 4.31 24 6 30 
Note. M = mean; SD = standard deviation 
The theoretical value for actual need ranged from 1 to 10.  
The theoretical value for perceived need ranged from 0 to 30.  
a Actual need refers to the number of chronic conditions that the participants had. 
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3.3 Objective 1 - To examine the influence of Predisposing Factors (age, education, and 
marital status) on men’s medication adherence.  
3.3.1 Age 
To analyse the association between age and medication adherence, a Pearson Product-
Moment Correlation Coefficient was used. There was a weak, positive correlation between 
age and medication adherence, which was statistically significant [r(445) = .27, p = 0.000]. 
This suggests that people who were older take more medication than people who were 
younger. 
3.3.2 Highest Level of Education 
 One-Way ANOVA was used to investigate the effect of education on medication 
adherence. All groups have a similar level of medication adherence, with men who had the 
highest education of TAFE, Apprentices, Trade Certificate, or Diploma having the highest 
medication adherence (M = 2.23, SD = 1.82) (Appendix C: Table C1). Table 4 shows there 
was not a significant effect of education on medication adherence [F(4,442) = .07, p = .991]. 
Therefore, no follow up analysis was conducted.  
Table 4 
One-Way Analysis of Variance (One-Way ANOVA) of Highest Level of Education by 
Medication Adherence (N = 447) 
 SS df MS F p 
Between Groups .942 4 .236 .071 .991 
Within Groups 1462.512 442 3.309   
Total 1463.454 446    
Note. SS = Sum of Squares; df = Degree of Freedoms; MS = Mean Square 
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3.3.3 Marital Status 
 One-way ANOVA was used to investigate the relationship between marital status and 
medication adherence. The number of medications taken by each subgroup was similar, with 
the widowed group taking the highest number of medications (M = 2.62, SD = 1.50) 
(Appendix C: Table C2). Table 5 shows that there was no significant difference between 
marital status and medication adherence [F(5,441) = 1.04, p = .391], hence no follow up 
analysis is required.   
 
Table 5 
One-Way Analysis of Variance (One-Way ANOVA) of Marital Status by Medication 
Adherence (N = 447) 
 SS df MS F p 
Between Groups 17.12 5 3.42 1.04 .391 
Within Groups 1446.34 441 3.28   
Total 1463.45 446    
Note. SS = Sum of Squares; df = Degree of Freedoms; MS = Mean Square 
 
3.4 Objective 2 - To examine the influence of Enabling Factor (Masculinity) on men’s 
medication adherence.  
Table 6 describes the summary of a Pearson Product-Moment Correlation conducted 
to determine the relationship between total masculinity of the MCD-I and the six MCD-I 
subscales (Strength, Sexual Importance, Family Responsibilities, Emotional Self-Reliance, 
Optimistic Capacity, Action Approach) with medication adherence. The relationship between 
the total masculinity and medication adherence was negatively correlated, r(445) = -.158, p 
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= .001. Other than Emotional Self-Reliance, the relationship between the MCD-I subscales 
and medication adherence were all statistically correlated with negatively weak correlations.  
This suggests that men with a higher level of masculinity was associated with a lower level of 
medication adherence.  Moreover, men who had a greater belief in physical strength, sexual 
importance, protective over partner and family, positive in life, and likely to take actions 
were associated with lower medication adherence.  
 
Table 6 
Pearson Product-Moment Correlation Coefficient Between Masculinity in Chronic Disease 
Inventory (MCD-I) Scores and Medication Adherence (N = 447)  
 M SD Medication 
Adherence 
p 
Total Masculinity  82.74 13.13 -.158* .001* 
Strength  18.09 3.87 -.111* .019* 
Sexual Importance/Priority  13.75 4.85 -.152* .001* 
Family Responsibilities  17.17 3.36 -.104* .028* 
Emotional Self-Reliance  6.96 2.02 .028 .548 
Optimistic Capacity  15.28 3.03 -.104* .028* 
Action Approach  11.49 2.31 -.131* .005* 
Note. M = mean; SD = standard deviation; MCD-I = Masculinity of Chronic Disease 
Inventory. Adapted from “Measuring Masculinity in the Context of Chronic Disease” by S. 
K. Chamber, M. K., Hyde, J. L. Oliffe, L. Zajdlewicz, A. Lowe, A. C. Wooten, and J. Dunn, 
2015, Psychology of Men & Masculinity, 17, p. 232. 
* p < 0.05 
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3.5 Objective 3 - To examine the influence of Need factors on men’s medication 
adherence.  
3.5.1 Perceived Need 
 A Pearson Product-Moment Correlation was used to determine the relationship 
between perceived need and medication adherence. There was a weak, positive correlation 
between perceived need and medication adherence, which was statistically significant (r(445) 
= .25, p = .000). Thus, people who rated their health as excellent have a higher rate of 
adherence to medication than people who have rated their health as poor. 
3.5.2 Actual Need 
An Independent Sample t-test was performed to compare the mean of two groups 
in actual need (one chronic condition vs multimorbidity) to determine whether there was 
a statistically significant difference between their medication adherence. Results shown 
in Table 7 demonstrate that the mean medication adherence differs between participants 
with one chronic condition (M = 1.38, SD = 1.4, n  = 176) and participants with 
multimorbidity (M = 2.72, SD = 1.85, n = 271) at the .05 level of significance (t = -8.18, 
df = 445, p < .001, 95% CI for mean difference -1.66 to -1.02). On average, participants 
with multimorbidity tend to have higher medication adherence than participants with 
only one chronic condition. A large effect size was found between actual need and 
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Table 7 
Result of Independent Samples T-test and Descriptive Statistics for Medication Adherence by 
Actual Need (N=447) 
 Actual Needa  
 
95% CI for 
Mean Difference 
   
 One Chronic 
Condition 
 Multimorbidity 
 M SD N  M SD N t df Cohen’s D 
Medication 
Adherence 
1.38 1.40 176  2.72 1.85 271 -1.66,-1.02 -8.18** 445 -1.34 
Note. M = mean; SD = standard deviation  
** p < .001. 
a Actual Need refers to the number of chronic conditions that the participants had. 
 
3.6 Objective 4 - To examine the relationship between Predisposing Factors, Enabling 
Factors, and Need Factors with medication adherence, after adjusting for significant 
covariance 
In order to identify the independent predictors of medication adherence, a multiple 
linear regression was performed. The total masculinity of the MCD-I has been removed from 
the multiple linear regression as it violated the assumption of multicollinearity (VIF = 45.7) 
(Appendix D). After removing the total masculinity, all assumptions of multiple linear 
regression were established (Appendix E). Table 8 shows a significant regression equation 
was found [F(8,438) = 13.86, p=0.000], R2 = .449 (R2 Adj = .187). Participants’ predicted 
medication adherence can be calculated by -3.06 + 0.04 (age) + 0.07 (perceived need) + 1.03 
(actual need). Age, perceived need, and actual need were significant predictors of medication 
adherence. Aligning with this, actual need played the most important factor in predicting 
medication adherence, followed by age, then perceived need. In other words, medication 
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adherence increases when age, perceived need, and actual need increases. Therefore, people 
who were older, had a higher score on self-assessed health status, and more chronic 
conditions were associated with better adherence. Furthermore, the results of multiple linear 
regression showed that the five subscales of the MCD-I (strength, sexual importance, family 
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Table 8 
Age, Masculinity (Five Subscales), Perceived Need, Actual Need as Predictors of Medication 
Adherence 
Variable B SE β t p 95% CI 
(Constant) -3.07 .96  -3.18 .002* [-4.96, -1.17] 
Age 0.04 .01 .23 4.68 .000** [0.03,0.06] 
MCD-Ia       
    Strength  0.00 .03 .01 .09 .926 [-0.05, 0.06] 
    Sexual Importance  0.01 .02 .04 .72 .475 [-0.03,0.5] 
    Family Responsibility -0.02 .03 -.03 -.64 .526 [-0.07,0.04] 
    Optimistic  0.02 .04 .04 .58 .560 [-0.05,0.09] 
    Action Based  -0.05 .05 -.06 -.98 .328 [-0.15,0.05] 
Perceived Need 0.07 .02 .16 3.20 .001* [0.03,0.11] 
Actual Need 1.03 .17 .28 6.14 .000** [0.70,1.36] 
Note: R2 = .449 (R2  Adj = .187) 
aMCD-I = Masculinity in Chronic Disease Inventory. Adapted from “Measuring Masculinity 
in the Context of Chronic Disease” by S. K. Chamber, M. K., Hyde, J. L. Oliffe, L. 
Zajdlewicz, A. Lowe, A. C. Wooten, and J. Dunn, 2015, Psychology of Men & Masculinity, 
17, p. 232. 
* p < 0.05 
** p < 0.001 
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CHAPTER 4 - Discussion 
4.1 Summary of General Findings 
The current study aimed to use the Andersen Behavioural Model to explain 
medication adherence in Australian men with chronic conditions. This study first examined 
the relationship between predisposing, enabling, and need factors with medication adherence 
at a bivariate level, then used a model to explain factors that influence medication adherence.  
Age, perceived need, and actual need were significantly associated with medication 
adherence, both at a bivariate level and in a model. In terms of masculinity, total masculinity 
and five subscales (Strength, Sexual Importance, Family Responsibility, Optimistic, and 
Action-Based) were significantly associated with medication adherence at a bivariate level. 
However, the five subscales of masculinity lost significance when put in a model and total 
masculinity was removed from the model as it violated the assumption of multicollinearity. 
Two variables were not significantly associated with medication adherence, which were 
education level and marital status. Therefore, using the Andersen Behavioural Model, the 
current study found age, perceived need, and actual need were associated with the rate of 
medication adherence.  
 
4.1.1 Objective 1 - To examine the influence of Predisposing Factors (age, education, and 
marital status) on men’s medication adherence 
Objective one was partially supported. Age was significantly correlated to medication 
adherence, with a weak positive correlation. Contrary to expectation, education level and 
marital status did not have a significant relationship with medication. 
Findings shown above indicate that age was positively related to medication 
adherence, as it was hypothesised. This finding was consistent with study done by 
Drewnowski and Evans (2001), which supports the hypothesis where older adults have better 
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health consciousness than younger adults, leading them to take medications as prescribed. 
Furthermore, older people are more prone to multimorbidity, which requires them to take 
more medications for different chronic conditions (Kocurek, 2009). 
Although findings of the present study have shown that people with lower education 
have poorer medication adherence due to lack of health literacy, yet the relationship was not 
significant. Perhaps, one possible explanation could be due to people with lower levels of 
education are more faithful to the medications prescribed by their doctors, believing that the 
doctor is more knowledgeable than they are, while people with higher education tend to seek 
alternative treatments (Tomar et al., 2019). In addition, people with higher education are 
more aware of the side effects of medication, as they have better medical knowledge than 
individuals with lower education level (Pandey et al., 2017).  
Contrary to the expectation, men who are married did not have the highest rate of 
adherence. Instead, widowed men have the highest medication adherence rate, though the 
relationship is not significant. This result was surprising, as past literature has consistently 
indicated that widowed men have poor adherence (Alhaddad et al., 2016; Dabaghian et al., 
2016; Pietrzykowski et al., 2020). Possibly, their partner could die from chronic conditions 
which makes them place greater emphasis on their health than others, leading to a higher 
medication rate. Therefore, it would be of interest to explore whether the causes of death of 
their partner have an influence on their help-seeking behaviour. 
 
4.1.2 Objective 2 - To examine the influence of Enabling Factor (masculinity) on men’s 
medication adherence  
In terms of masculinity, the hypothesis was mostly supported, as the total masculinity 
and all subscales were significantly negatively associated with medication adherence, except 
for emotional self-reliance, which appears to not be significantly associated with medication 
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adherence. These findings are consistent with previous literature, as the masculinity norms 
encourage people to put their health at risk, in order to maintain the notion of masculinity 
(Mahalik et al., 2007). Aligning with this, people with higher masculinity would consider that 
having chronic conditions can threaten their masculine identity, hence, making them to be 
ignorant in seeking help (Courtenay, 2000). 
 
4.1.3 Objective 3 – To examine the influence of Need Factors on men’s medication 
adherence  
The perceived need was positively correlated to medication adherence, as 
hypothesised. This is supported by the previous study, which supports the notion of people 
with better self-perceived health would attempt to sustain their health, preventing their 
chronic conditions from worsening, which associates them to have better adherence to 
medication (DiMatteo et al., 2002).  
Unexpectedly, thought the relationship between actual need and medication adherence 
was significant, the relationship was positively correlated. This may possibly be due to the 
current study using the number of medication taken as the proxy measure for medication 
adherence, as people with multimorbidity tend to take more medication than people with one 
chronic condition (Wehling, 2009), leading to a positive correlation between actual need and 
medication adherence. Therefore, future research should use various methods to measure 
medication adherence, taking different factors into account such as the number of 
medications required, dose frequency, and severity of chronic conditions (Brown & Bussell, 
2011). 
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4.1.4 Objective 4 – To examine the relationship between Predisposing Factors, Enabling 
Factors, and Need Factors with medication adherence, after adjusting for significant 
covariance  
Age, perceived need, and actual need remain significant after adjusting for other 
significant covariates. This finding is consistent with previous literature, since older men are 
more likely to have multimorbidity and are less likely than younger men to be judged on their 
own health status. Thus, they are more likely to have the needs to take multiple medications 
to treat various chronic conditions that they have had (Benyamini & Burns, 2019; Chan et al., 
2013).  
Interestingly, although the five subscales of the MCD-I (Strength, Sexual Importance, 
Family Responsibility, Optimistic, and Action-Based) were significant at a bivariate level, all 
of them lost significance after adjusting for other significant covariates. Moreover, the 
relationship between Strength, Sexual Importance, and Optimistic with medication adherence 
changed direction after putting them in multiple linear regression, though the relationships 
were not significant. Other than that, even though the total masculinity was significant at a 
bivariate level, it was not included in the multiple linear regression as it violated the 
assumption of multicollinearity. One possible explanation of the findings found in this study 
could be that the participants in the current research were quite old (M=65.73, SD = 9.33), 
which brings them to focuson their health more than their masculinity level. For instance, 
Mahalik and Levi-Minzi (2007) recruited Australian men (M= 32.98, SD = 13.14) to 
participate in their research and found that masculinity to be significantly associated with 
harmful health behaviours. Thus, the association between masculinity and medication 
adherence could be dependent on the participants’ age. Furthermore, older men have more 
experience in life, which enhances their ability to perceive resilience (Tannenbaum & Frank, 
2010). In addition, older men tend to experience less social pressure to conform and maintain 
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masculinity values compared to younger men (Solomon & Schopler, 1982). Thus, this could 
explain the reason why masculinity lost significance after adjusting for significant covariates. 
Moreover, this study used a new masculinity measure, which is the MCD-I measure, which 
can cause results to be different from previous study as different traits were measured in both 
scales. For instance, study done by Mahalik and Levi-Minzi (2007) used the Conformity to 
Masculine Norms Inventory (CMNI) measures to evaluate masculinity, which assess certain 
factors that were not included in the MCD-I, such as violence, risk-taking, and playboy. The 
study found masculinity to be associated with harmful health behaviours. Therefore, it would 
be of interest for future research to explore how masculinity varies between age groups and 
influence their medication adherence, and also the differences in findings by using different 
measures. 
4.2 Strengths of the Current Study 
As the literature on factors that influence medication adherence in Australian men 
with a chronic condition is limited, the current study brought to light how socioeconomic 
status, masculinity, perceived health status, and the number of chronic conditions impact the 
rate of adherence. To date, there has been no research in Australia using the Andersen 
Behavioural Model to capture how medication adherence can be influenced by various 
factors. Using the Andersen Behavioural Model as a theoretical framework is important, as it 
provides information regarding the weight of influences of different variables on medication 
adherence and highlight how different predictor variables might differ when accounting for 
other predictor variables (Grant & Osanloo, 2015). Thus, this study provides a direction for 
future study on factors that influence the rate of adherence and a better understanding of how 
different factors can influence each other. 
Another strength of the study was using the MCD-I in measuring masculinity, which 
conceptualised masculinity ideals for Australian men with a chronic condition (Chambers et 
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al., 2016). As masculinity traits can differ across cultures and region (Lease et al., 2013), by 
using the MCD-I that was developed in Australia, focusing on the older men, which is closely 
related to the sample used in this study, allowing the findings of the study to be more valid 
and less bias. In addition, the MCD-I was developed based on modern masculinity, which 
takes into consideration men’s emotion (Occhipinti et al., 2019). 
 
4.3 Limitations of the Current Study  
4.3.1 Generalisability 
               Although an extensive sample was used in the current study, some groups were 
overly represented. The majority of the sample participants were older, married, and retired 
men, resulting in the external validity of the study, which may be limited to this demographic. 
Thus, further research has to be done targeting other male populations. 
 As the present study used existing data, some important variables that could 
potentially affect the results were not collected, such as sexual preference. Sexual preference 
plays a role in help-seeking behaviour which can influence the level of medication adherence, 
as people who are non-heterosexual are more reluctant to seek help due to discrimination and 
victimisation (Fredriksen-Goldsen et al., 2014). In addition, non-heterosexual adults are more 
likely to experience chronic stressors, which can affect an individual’s physical health over 
the lifespan, making them more prone to multimorbidity (Juster et al., 2009). As men with 
different sexual preference have different rates of seeking help, the results of the current 
study can be slightly inapplicable to men with certain sexual preference. As a result, future 
research should examine the impact of sexual orientation on help-seeking behaviour and 
medication adherence, as well as specify the targeted sexual preference group that they are 
investigating.  
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4.3.2 Limitation of the Measures 
In the present study, the number of medications taken was used as the proxy measure 
of medication adherence, which may not be an accurate indicator of medication adherence 
due to various reasons. For instance, each participant was required to take a different amount 
of medication prescribed, and some medication can be used to treat two chronic conditions 
simultaneously (Huber et al., 2013). Furthermore, the use of a medication may contraindicate 
with the use of another medication, which may possibly lead the patients to neglect the less 
important one (Costa et al., 2015). Other than that, some medications require a higher dosing 
frequency per day to be effective (Richter et al., 2003). Dosing frequency also has an impact 
in adherence rate as older adults are more likely to adhere to once-a-day medication than 
twice-a-day medication (Ingersoll & Cohen, 2008). However, the current study did not 
consider any of these factors. As a result, having to take a lesser amount of medication does 
not necessarily align with less adherence. 
 Due to the nature of the data collected, the present study did not take into account 
medications that were prescribed versus over-the-counter medications. The type of 
medication included in this study consists of supplements and prescribed medications. Some 
participants claim to take supplements such as multivitamins to treat high blood pressure and 
high cholesterol, which leads the current study to include supplements as one of the options 
for the type of medication taken. Therefore, future research can focus on the number of 
medications prescribed and the number of medications that the individuals are consuming, to 
understand better whether individuals are adherent to medications that they are required to 
consume. 
4.3.3 Self-Report Measures 
The current study collected data through self-report measures, which possibly leads to 
social desirability bias, as participants may not want to disclose certain information. As a 
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result, participants in the current study could respond in a manner that portraits their positive 
traits, such as over reporting ‘good behaviour’ and under reporting ‘bad behaviour’ (Paulhus, 
2002). Furthermore, masculinity is a sensitive construct. Participants might want to impress 
the researcher by selecting responses that correspond to the ideal masculinity traits, hence 
resulting in skewed and false answers. 
4.3.4 Distribution of the Data 
The results of the current study, however, have to be taken with caveats, because not 
all assumptions were met. For instance, the assumption of normality for medication 
adherence was not met. The data for medication adherence was skewed, as there were fewer 
people taking seven to eight medications, which results in the distribution to be positively 
skewed. Although the current study used the Central Limit Theorem (CLT) to assume 
normality, the results can be slightly inapplicable, as the sample used may not be drawn for a 
normally distributed population. Even though the current study could transform the data to fit 
the assumption of normality better, transformed data could result in data being hard to 
interpret, as well as generating an inaccurate estimate of the original data (Feng et al., 2014). 
As a result, although the findings of the current study are still applicable, it has to be taken 
with caveat. 
4.3.5 Cross-Sectional Study  
The findings of the present study were not able to establish a cause and effect 
relationship due to the fact that this is a cross-sectional study. Instead, this study can solely 
comment on whether variables are associated. Hence, it can be difficult to draw conclusions 
on the basis of the results found in this research. Therefore, it is difficult for this study to 
determine whether the predictor variables (age, perceived need, and actual need) or 
medication adherence came first. This is because the current study was only able to examine 
whether there is an association between variables instead of establishing a cause and effect.  
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Although the cross-sectional study can be carried out relatively quickly as data are 
collected at a single point of time, a cross-sectional study is not able to analyse behaviour 
over an extended period of time. As a result, the present study is unable to understand the 
factors that affect medication adherence in the long run. In addition, factors that influence 
medication adherence may alter over time, which will most likely cause the findings of the 
current study to be less relevant in the future. 
4.4 Theoretical and Practical Implications 
Firstly, the results of the current study helped to improve the limited knowledge of 
factors influencing medication adherence by using the Andersen Behavioural Model. While 
most research investigating the relationship between masculinity and medication adherence 
was done in the United States, this study was conducted in Australia, hence enabling the 
findings of the current study to be applied to Australian men. As a result, professionals are 
able to provide treatments that are more appropriate for Australian men as findings of the 
current study are based on Australian men.   
               Secondly, the present study indicated that older men have better medication 
adherence than younger men. This could be the fact that younger men are more likely to have 
a full-time job, which possibly results in them to neglect the intake of medication. Hence, 
professionals could provide age-appropriate health assessments and medication towards 
patients in a different age group. For instance, professionals can prescribe a medication that 
has a lower dosing frequency to younger men, so that it will not cause an inconvenience for 
them to consume the medication a few times a day. Another suggestion for health 
professionals could be prescribing a multi-purpose drug to younger men, allowing them to 
receive a similar effect from the medications while taking less amount of medication.  
Thirdly, the present study has demonstrated that self-assessed health status has an 
impact on medication adherence. Therefore, professionals should take into consideration of 
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how individuals view their own health when prescribing medication, for better catering of 
their needs. For instance, professionals can ask the individuals how they would rate their own 
health before prescribing medication, as the current study has found that people who self-
rated highly on health status have better adherence to medication. Thus, when prescribing 
medications to individuals who poorly self-assessed their health status, professionals can ask 
for their opinion on whether they are comfortable with the number of medications prescribed 
and whether they would take the prescribed medications.  
 
4.5 Recommendations for Future Research 
Firstly, even though the literature has shown that sexual preference can influence an 
individual’s behaviour for seeking help, the current study did not collect the participants’ 
sexual preference. On that account, the influence of sexual preferences on medication was 
unable to be investigated. Consequently, future research could collect participants’ sexual 
preferences, in order to investigate how medication adherence differs between people with 
different sexual orientations. 
Secondly, the reason masculinity lost significance with medication adherence after 
putting it in the model could be explained by the fact that older men were overly represented 
in this study as masculinity was known to be low in older men. Moreover, the work status 
and education level of the participants in the present study were not evenly distributed, which 
could cause them to not have a significant effect on medication adherence. There were a few 
groups in this study that were overly represented, such as men aged 60 to 69, married, and 
retired, causing the findings of this study to be more applicable to this population. Therefore, 
further research should aim to ensure the number of participants demographic characteristics 
in each group (age, work status, education level, annual income) are similar, without one 
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group being over-represented and another group being under-represented, to ensure maximal 
external validity. 
Thirdly, as mentioned above, the measure of medication adherence might not be an 
accurate representation of medication adherence because the number of medications taken 
does not necessarily indicate better adherence. Some medications can be used to treat two 
chronic conditions simultaneously, while some chronic conditions require multiple 
medications (Huber et al., 2013). Thus, future research could use different methods to 
measure adherence, such as interviewing patients and family, counting pills, or checking rates 
of prescription refill records, depending on the nature of the study. 
Fourthly, although this study has accounted for many variables, but there are still 
many other variables out there that were not considered, such as cost, dosing frequency, side 
effects, and patients’ beliefs (Egan et al., 2003; Vermeire et al., 2001). Having a lower cost, 
lesser dosing frequency, and minor side effects can allow a person to be more adherent to 
medication. Furthermore, evidence has shown poor understanding of medication can also 
lead to poor adherence as the patients do not understand the aftermath of poor adherence 
(Brown & Bussell, 2011). This has been further supported by the survey of Medicare 
beneficiaries, as respondents have reported that they do not think some medicine were 
necessarily needed. The survey has also found medicines that are not covered by insurance 
can lead to lower adherence, as the cost of medication can be a burden to some people 
(Kennedy et al., 2008). Thus, it would be of interest in future research to examine the 
influence of patients’ beliefs and characteristics of medication in terms of their medication 
adherence rate.  
4.6 Conclusions  
The number of people with chronic conditions in Australia has been accelerating for 
the past decade (Australian Health Ministers’ Advisory Council, 2017). Despite having more 
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people diagnosed with chronic conditions, the rate of medication adherence remains the 
same, with approximately 50% of patients not taking their medications as prescribed  
(Liestyo & Santella, 2003; Pharmaceutical Society of Australia, 2006). Unfortunately, little 
research has been done using a theoretical framework to understand medication adherence. 
Thus, the current study addresses how different factors can influence medication adherence 
while accounting for other predictor factors, which then contribute to the knowledge of 
factors that influence the rate of adherence. In addition, the current study has suggested the 
socioeconomic status influences patients’ medication adherence behaviour, which allows 
professionals to prescribe medication more mindfully while considering the patients’ 
socioeconomic status. Furthermore, the current finding has shown men in different age 
groups have different levels of medication adherence, which enable professionals to prescribe 
age-appropriate medication, in order to fulfil the needs of patients in different age groups. 
               In addition, the current study found that how individuals perceive their health status 
and the number of chronic conditions they have can influence their rate of medication 
adherence. People who perceived themselves as having better health and people with more 
chronic conditions have a higher level of adherence. Furthermore, the present study not only 
provides a significant contribution to the existing literature regarding factors that influence 
Australian men’s medication adherence behaviour but also suggest crucial directions for 
future research. 
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Appendix B – Descriptive Statistics of Study Participants 
Table B1 
Descriptive Statistics of Masculinity (MCD-I) (N=447) 
Variable M Median SD Minimum Maximum Range 
Total masculinitya 82.74 83 13.13 34 108 74 
Strengtha 18.09 18 3.87 9 25 16 
Sexual Importancea 13.75 15 4.85 4 20 16 
Family Responsibilitiesa 17.17 18 3.36 4 20 16 
Emotional Self-Reliancea 6.96 7 2.02 2 10 8 
Optimistica 15.28 15 3.02 5 20 15 
Action Baseda 11.49 12 2.31 3 15 12 
Note. M = mean; SD = standard deviation;  MCD-I = Masculinity of Chronic Disease 
Inventory. Adapted from “Measuring Masculinity in the Context of Chronic Disease” by S. 
K. Chamber, M. K., Hyde, J. L. Oliffe, L. Zajdlewicz, A. Lowe, A. C. Wooten, and J. Dunn, 
2015, Psychology of Men & Masculinity, 17, p. 232. 
a The theoretical value for total masculinity, strength, sexual importance, family 
responsibilities, emotional self-reliance, optimistic, and action based ranged from 0 to 110, 
25, 20, 20, 10, 20, and 15, respectively.  
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Table B2 
Descriptive Statistics of Chronic Conditions of Study Participants (N=447) 
Chronic Condition n  % 
Heart Attack a 38 8.5 
Stroke a 10 2.2 
Angina a 33 7.4 
Transient Ischemic Attack / Mini Stroke a 10 2.2 
Atrial Fibrillation 28 6.3 
Kidney/Renal Disease 17 3.8 
High Blood Pressure 227 50.8 
High Cholesterol 194 43.4 
Smoking Related Lung Condition (COPD, 
COAD, Emphysema or Bronchitis) b 
19 4.3 
Parkinson’s Disease 1 0.2 
Asthma 60 13.4 
Enlarged Prostate/Benign Prostatic 
Hyperplasia (BPH) 
92 20.6 
Diabetes 71 15.9 
Hyperthyroidism (Overactive Thyroid) 5 1.1 
Hyperthyroidism (Underactive Thyroid) 6 1.3 
Osteoarthritis 127 28.4 
Osteoporosis 21 4.7 
Gout 57 12.8 
a Heart attack, stroke, angina, and transient ischemic attack/mini stroke are considered as 
coronary heart disease. 
b COPD = Chronic Obstructive Pulmonary Disease  
  COAD = Chronic Obstructive Airway Disease 
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Table B3 
Descriptive Statistics of Medication Adherence of Study Participants (N=447) 
Variable n % 
Number of Medications    
0 97 21.7 
1 78 17.4 
2 102 22.8 
3 74 16.6 
4 42 9.4 
5 25 5.6 
6 21 4.7 
7 7 1.6 
8 1 0.2 
Types of Medication   
Multivitamins and Minerals 76 17 
Multivitamins Alone 29 6.5 
Fish Oil 111 24.8 
Glucosamine 63 14.1 
Omega 3 19 4.3 
Paracetemol 109 24.4 
Codeine 26 5.8 
Aspirin 101 22.6 
Lipitor 77 17.2 
Avapro, Karvea 23 5.1 
Warfarin, Courmadin 19 4.3 
Pravachol 4 0.9 
Coversyl, Coversyl Plus 42 9.4 
Lasix, Frusemide 4 0.9 
Zocor, Lipex 14 3.1 
Cardizem, Vasocordol 12 2.7 
Micardis 32 7.2 
Nexium 32 7.2 
Norvasc 2 0.4 
FACTORS AFFECTING  MEDICATION ADHERENCE  98 
 
Fosamax 3 0.7 
Somac 25 5.6 
Tritace 6 1.3 
Caltrate 18 4.0 
Acimax (Omeprazole) 10 2.2 
Biten, Tenormin (Artenolol) 21 4.7 
Oroxine (Thyroxine) 7 1.6 
Ventolin (Salbutamol) 27 6.0 
Zyloprim, Progout 300 (Allopurinol) 17 3.8 
Diaformin (Melformin) 40 8.9 
Zoloft (Sertraline) 6 1.3 
Cipramil (Citalopram) 2 0.4 
Efexor (Venlafaxine) 3 0.7 
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Appendix C -  The Number of Medication Taken for Each Education Levels and 
Marital Status 
Table C1 
Marital Status of Study Participants (N=447) 
 N M SD Std. Error 95% CI 
Married 345 2.25 1.81 .10 [2.06,2.44] 
Living with a Partner (Defacto) 33 2.06 2.01 .35 [1.35,2.78] 
Widowed 13 2.62 1.50 .42 [1.71,3.52] 
Divorced 27 2.04 1.79 .34 [1.33,2.74] 
Separated 16 1.31 1.82 .45 [.35,.2.28] 
Never Married 13 2.08 1.71 .47 [1.05,3.11] 
Note. M = mean; SD = standard deviation; CI = confidence interval 
 
Table C2 
 Highest Education Level of Study Participants (N=447) (descriptive stats of marital status vs 
medication adherence!!!) 
 N M SD Std. Error 95% CI 
Primary School  24 2.17 1.58 .32 [1.50,2.83] 
High School 143 2.18 1.86 .16 [1.87,2.49] 
TAFE/Apprentices/Trade 
Certificate/ Diploma 
197 2.23 1.82 .13 [1.98,2.49] 
Bachelor Degree or Higher 69 2.10 1.76 .21 [1.68,2.52] 
Other 14 2.21 2.01 .54 [1.06,3.37] 
Note. M = mean; SD = standard deviation; CI = confidence interval 
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